Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRESS: Mirasol-treated Platelets in Thrombocytopenic Patients
NCT01368211Phase 3Terminated
- Sponsor
- Terumo
- Start
- Sep 2010
- Primary completion
- Apr 2011
- Modality
- Cell Therapies, Device-based Delivery
- Countries
- 1
01
Overview
A Phase 3 trial of Mirasol-treated red blood cells in Thrombocytopenia, sponsored by Terumo. Started Sep 2010; status: terminated.
02
Drugs
Mirasol-treated red blood cells
03
Conditions
Thrombocytopenia
Beyond the preview
Go deeper on NCT01368211.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01368211.